Unlocking the Power of Minor Cannabinoids: CBDA, THCA, and CBGA

Name: Unlocking the Power of Minor Cannabinoids: CBDA, THCA, and CBGA
Uploaded: 2025-05-16 19:50:43
Description: This webinar explores the unique therapeutic potential of acidic cannabinoids—CBDA, THCA, and CBGA—in addressing inflammation, nausea, neuroprotection, and more. Learn the latest science, clinical applications, and dosing considerations for incorporating these effective and safe compounds into patient care.

Education Webinars Unlocking the Power of Minor Cannabinoids: CBDA, THCA, and CBGA

This webinar explores the unique therapeutic potential of acidic cannabinoids—CBDA, THCA, and CBGA—in addressing inflammation, nausea, neuroprotection, and more. Learn the latest science, clinical applications, and dosing considerations for incorporating these effective and safe compounds into patient care.

Integrate Powerful Hemp Cannabinoids into your Healthcare Practice

Learn from leading cannabis clinician Bonni Goldstein, MD and grow your practice revenues through our lab-tested hemp extract marketplace, while providing an exclusive medical discount to your patients. For a limited time, our platform is free for licensed US healthcare practitioners only.

With your free account, you'll get access to this educational video and so much more!

Learn more Create your free account

View Sources

Anderson, L. L., Low, I. K., Banister, S. D., McGregor, I. S., & Arnold, J. C. (2019). Pharmacokinetics of phytocannabinoid acids and anticonvulsant effect of cannabidiolic acid in a mouse model of Dravet syndrome. Journal of Natural Products, 82(11), 3047–3055.

Anderson, L. L., et al. (2021). Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy. British Journal of Pharmacology, 178(24), 4826–4841.

Appendino, G., Gibbons, S., Giana, A., Pagani, A., Grassi, G., Stavri, M., … Rahman, M. M. (2008). Antibacterial cannabinoids from Cannabis sativa: A structure–activity study. Journal of Natural Products, 71(8), 1427–1430.

Ben-Cnaan, E., Cohen-Yeshurun, A., Winder, A., et al. (2022). The metabolic efficacy of a cannabidiolic acid (CBDA) derivative in treating diet- and genetic-induced obesity. International Journal of Molecular Sciences, 23(10), 5610.

Bolognini, D., Rock, E. M., Cluny, N. L., Cascio, M. G., Limebeer, C. L., Duncan, M., … Parker, L. A. (2013). Cannabidiolic acid is a potent PPARα agonist and 5-HT1A receptor modulator. British Journal of Pharmacology, 168(6), 1456–1470.

De Petrocellis, L., Ligresti, A., Moriello, A. S., Allarà, M., Bisogno, T., Petrosino, S., & Di Marzo, V. (2011). Effects of cannabinoids and cannabinoid-enriched cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. British Journal of Pharmacology, 163(7), 1479–1494.

De Petrocellis, L., et al. (2012). Cannabidiolic acid inhibits breast cancer cell migration through inhibition of COX-2 expression. Journal of Pharmacology and Experimental Therapeutics, 340(2), 294–301.

De Petrocellis, L., et al. (2008). Cannabinoid interactions with TRP channels and endocannabinoid system targets. Current Medicinal Chemistry, 15(24), 2534–2544.

D’Aniello, E., et al. (2019). Identification and characterization of phytocannabinoids as novel dual PPARα/γ agonists by computational and in vitro experimental approach. Biochimica et Biophysica Acta (BBA) - General Subjects, 1863(3), 586–597.

Faouzi, M., et al. (2022). Acidic cannabinoids suppress proinflammatory cytokine release by blocking store-operated calcium entry. Function, 3(4), zqac033.

Fellous, T., De Maio, F., Kalkan, H., et al. (2020). Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells. Biochemical Pharmacology, 175, 113859.

Formato, M., Crescente, G., Scognamiglio, M., et al. (2020). (−)-Cannabidiolic acid, an overlooked bioactive compound: An introductory review. Molecules, 25(11), 2638.

Hen-Shoval, D., Moshe, L., Indig-Naimer, T., et al. (2023). Cannabinoid receptor 2 blockade prevents anti-depressive-like effect of cannabidiol acid methyl ester in female WKY rats. International Journal of Molecular Sciences, 24(4), 3828.

Herrera, J. G., et al. (2024). Analysis of cannabinoids in medicinal cannabis products: A comprehensive review. Journal of the Brazilian Chemical Society, 35(10), e20240129.

Kim, J., Park, S., Choi, Y., et al. (2023). Cannabinoids CBDA and THCA rescue memory deficits and reduce amyloid-beta and tau pathology in an Alzheimer’s disease-like mouse model. International Journal of Molecular Sciences, 24(7), 6827.

Milligan, C. J., Li, Y., et al. (2023). Beyond CBD: Inhibitory effects of lesser studied phytocannabinoids on human voltage-gated sodium channels. Frontiers in Physiology, 14, 1081186.

Rock, E. M., & Parker, L. A. (2013). Effect of low doses of cannabidiolic acid on nausea and vomiting in rats. British Journal of Pharmacology, 169(1), 262–276.

Rock, E. M., Limebeer, C. L., & Parker, L. A. (2017). Effect of cannabidiolic acid and its methyl ester on anxiety-like behavior in rats. British Journal of Pharmacology, 174(18), 3169–3181.

Rock, E. M., Limebeer, C. L., Petrie, G. N., Williams, L. A., Mechoulam, R., & Parker, L. A. (2017). Effect of prior foot shock stress and cannabinoids on anxiety-like responding in rats. Psychopharmacology, 234(14), 2207–2217.

Rock, E. M., Limebeer, C. L., & Parker, L. A. (2018). Effect of cannabidiolic acid and Δ9-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in rats. Psychopharmacology, 235(11), 3259–3271.

Rock, E. M., Limebeer, C. L., Parker, L. A., et al. (2020). Cannabidiolic acid enhances the anti-nausea effects of ondansetron in preclinical models. European Journal of Pharmacology, 878, 173104.

Senevirathne, G. I., et al. (2025). Understanding the role of oxylipins in cannabis to enhance cannabinoid production. Frontiers in Plant Science, 16, 1568548.

Suzuki, S., Fleig, A., & Penner, R. (2023). CBGA ameliorates inflammation and fibrosis in nephropathy. Scientific Reports, 13(1), 6341.

Suzuki, S., et al. (2024). Cannabigerolic acid inhibits the TRPM7 ion channel through its kinase domain. Function, 5(1), zqad069.

Takeda, S., Misawa, K., Yamamoto, I., & Watanabe, K. (2008). Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis. Drug Metabolism and Disposition, 36(9), 1917–1921.

van Breemen, R. B., Muchiri, R. N., Bates, T. A., Weinstein, J. B., Leier, H. C., Farley, S., … Tafesse, F. G. (2022). Cannabinoids block cellular entry of SARS-CoV-2 and emerging variants. Journal of Natural Products, 85(1), 176–184.

Collapse